| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-06 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-05 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |